| 1.89 Real-Time Quote |  +0.05 / +2.72%Today’s Change | 0.70 Today|||52-Week Range 2.17 | +148.68% Year-to-Date |
| Previous close | 1.84 |
| Today’s open | 1.84 |
| Day’s range | 1.82 - 1.89 |
| Volume | 252,417 |
| Average volume (3 months) | 1,631,950 |
| Market cap | $123.4M |
| Dividend yield | -- |
| Earnings growth (last year) | +44.05% |
| Earnings growth (this year) | +32.34% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.76 |
| Today’s change | Today’s % change | |
|---|---|---|
| FLMLFlamel Technologies ... | +0.03 | +0.64% |
| PTXPernix Therapeutics ... | -0.02 | -0.56% |
| APPAA.P. Pharma Inc | -0.01 | -2.30% |
| GENTGentium SpA | +0.02 | +0.23% |
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$31.7M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & VP-Operations Joseph G. Oliveto, MBA |
Chief Financial Officer & VP-Administration J. Nick Riehle, MBA |
Corporate headquarters Charlotte, North Carolina |
.
